Lyon (France), Philadelphia (USA), November 24 2009.

ERYtech Pharma has been awarded ISO9001:2008 Certification. The International Organization for Standardization is the world’s leading International Standards developer.

ISO 9001:2008 specifies the requirements which have been fulfilled by ERYtech in respect of quality assurance and a capacity to deliver products which are both consistent in quality and in compliance with regulatory and legal frameworks.

This Certification covers all the key departments of the Company, such as: Research & Development, Medical, Clinical and Regulatory affairs, Business Development and Production.

‘’This first ISO 9001:2008 Certificate for a French Biotech company is the result of the involvement of the whole team. It demonstrates our internal culture of excellence The ISO certification is a further crucial milestone in certification. ERYtech recently obtained the manufacturing licence for cell therapy medicinal products (Etablissement Pharmaceutique). ERYtech Pharma also intends to achieve excellence in this field”, says Pierre-Olivier Goineau, EVP Corporate & Business Development and Co-founder of ERYtech Pharma.

About ERYtech Pharma

ERYtech Pharma is a specialty pharma company developing innovative therapeutic products based on its proprietary technology and expertise in the physiological properties of erythrocytes. The company addresses serious pathologies, orphan indications or sub-populations of patients, particularly in the fields of haematology, cancer and metabolic diseases.

Press Contact :

ERYtech Pharma – 60, Avenue Rockefeller – Bâtiment Adénine – 69008 – LYON – France

ERYtech Pharma – US Office – 3711 Market Street, 19104 Philadelphia PA – USA

contact@erytech.com